ENDRA Life Sciences (NDRA) Consolidated Net Income: 2016-2021
Historic Consolidated Net Income for ENDRA Life Sciences (NDRA) over the last 6 years, with Dec 2021 value amounting to -$3.1 million.
- ENDRA Life Sciences' Consolidated Net Income fell 37.94% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.2 million, marking a year-over-year increase of 4.22%. This contributed to the annual value of -$11.5 million for FY2024, which is 14.39% down from last year.
- According to the latest figures from Q4 2021, ENDRA Life Sciences' Consolidated Net Income is -$3.1 million, which was down 16.79% from -$2.7 million recorded in Q3 2021.
- ENDRA Life Sciences' Consolidated Net Income's 5-year high stood at -$741,623 during Q1 2017, with a 5-year trough of -$4.8 million in Q4 2019.
- Over the past 3 years, ENDRA Life Sciences' median Consolidated Net Income value was -$3.0 million (recorded in 2020), while the average stood at -$3.0 million.
- In the last 5 years, ENDRA Life Sciences' Consolidated Net Income tumbled by 280.96% in 2018 and then skyrocketed by 53.20% in 2020.
- ENDRA Life Sciences' Consolidated Net Income (Quarterly) stood at -$2.3 million in 2017, then dropped by 3.09% to -$2.4 million in 2018, then tumbled by 103.30% to -$4.8 million in 2019, then soared by 53.20% to -$2.3 million in 2020, then tumbled by 37.94% to -$3.1 million in 2021.
- Its Consolidated Net Income stands at -$3.1 million for Q4 2021, versus -$2.7 million for Q3 2021 and -$3.2 million for Q2 2021.